Resultados da busca - Frank Jessen
- Mostrando 1 - 20 resultados de 134
- Ir para a próxima página
-
1
-
2
Patient eligibility for amyloid-targeting immunotherapies in Alzheimer's disease por Jurij Rosen, Frank Jessen
Publicado em 2025Artigo -
3
-
4
-
5
Anti-amyloid antibody therapies in Alzheimer’s disease por Robert Perneczky, Frank Jessen, Timo Grimmer, Johannes Levin, Agnes Flöel, Oliver Peters, Lutz Froelich
Publicado em 2023Artigo -
6
-
7
-
8
Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer’s disease por Frederic Brosseron, Andreas Traschütz, Catherine Widmann, Markus P. Kummer, Paweł Tacik, Francesco Santarelli, Frank Jessen, Michael T. Heneka
Publicado em 2018Artigo -
9
-
10
-
11
Mrp14 Deficiency Ameliorates Amyloid β Burden by Increasing Microglial Phagocytosis and Modulation of Amyloid Precursor Protein Processing por Markus P. Kummer, Thomas Vogl, Daisy Axt, Angelika Griep, Ana Vieira‐Saecker, Frank Jessen, Ellen Gelpí, Johannes Roth, Michael T. Heneka
Publicado em 2012Artigo -
12
-
13
Assessing blood-brain barrier dysfunction and its association with Alzheimer’s pathology, cognitive impairment and neuroinflammation por Lukas Preis, Kersten Villringer, Frederic Brosseron, Emrah Düzel, Frank Jessen, Gabor C. Petzold, Alfredo Ramı́rez, Annika Spottke, Jochen B. Fiebach, Oliver Peters
Publicado em 2024Artigo -
14
N-Acetylaspartylglutamate (NAAG) and N-Acetylaspartate (NAA) in Patients With Schizophrenia por Frank Jessen, Natascha Fingerhut, Alois M. Sprinkart, Kai‐Uwe Kühn, Nadine Petrovsky, Wolfgang Maier, H. H. Schild, Wolfgang Block, Michael Wagner, Frank Träber
Publicado em 2011Artigo -
15
Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline (SCD) por Lukas Scheef, Michel J. Grothe, Alexander Koppara, Marcel Daamen, Henning Boecker, H. J. Biersack, Hans H. Schild, Michael Wagner, Stefan Teipel, Frank Jessen
Publicado em 2018Artigo -
16
A systematic review of digital and face-to-face cognitive behavioral therapy for depression por Lana Kambeitz‐Ilankovic, Uma Rzayeva, Laura Völkel, Julian Wenzel, Johanna Weiske, Frank Jessen, Ulrich Reininghaus, Peter J. Uhlhaas, Mario Álvarez‐Jiménez, Joseph Kambeitz
Publicado em 2022Revisão -
17
The Role of Macrophage Migration Inhibitory Factor in Alzheimer’s Disease por Michael Bacher, Oliver Deuster, Bayan Aljabari, Rupert Egensperger, Frauke Neff, Frank Jessen, Julius Popp, Carmen Noelker, Jens Peter Reese, Yousef Al‐Abed, Richard Dodel
Publicado em 2010Artigo -
18
Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients por Dieter Lütjohann, Andreas Papassotiropoulos, Ingemar Björkhem, S. Locatelli, Metin Bagli, Randi D. Oehring, Uwe Schlegel, Frank Jessen, Marie Luise Rao, Klaus von Bergmann, Reinhard Heun
Publicado em 2000Artigo -
19
Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease por Gérard N. Bischof, Frank Jessen, Klaus Fließbach, Julian Dronse, Jochen Hammes, Bernd Neumaier, Oezguer A. Onur, Gereon R. Fink, Juraj Kukolja, Alexander Drzezga, Thilo van Eimeren
Publicado em 2016Artigo -
20
Neuroanatomical Characteristics Associated With Response to Deep Brain Stimulation of the Nucleus Basalis of Meynert for Alzheimer’s Disease por Juan Carlos Baldermann, K. Hardenacke, Xiaochen Hu, Phillip Köster, Andreas Horn, Hans‐Joachim Freund, Karl Zilles, Volker Sturm, Veerle Visser‐Vandewalle, Frank Jessen, David Maintz, Jens Kuhn
Publicado em 2017Artigo
Ferramentas de busca:
Assuntos relacionados
Medicine
Disease
Internal medicine
Dementia
Psychology
Pathology
Alzheimer's disease
Cognition
Psychiatry
Biology
Neuroscience
Cognitive decline
Gerontology
Gene
Genetics
Biochemistry
Radiology
Oncology
Magnetic resonance imaging
Biomarker
Cohort
Neurology
Clinical psychology
Cognitive impairment
Environmental health
Apolipoprotein E
Atrophy
Genotype
Neuroimaging
Population